The Biological Product Manufacturing industry's gross output in the U.S. is forecasted to grow steadily from 2024 to 2028, reaching 49.77 billion USD in 2028. Comparatively, the industry's actual output for 2023 is not provided, which complicates precise percentage-based trend analysis.
- 2024 sees a growth to 44.95 billion USD.
- 2025 is forecasted to achieve a value of 46.19 billion USD, marking a year-on-year increase from 2024.
- 2026 continues the upward trend with an output of 47.41 billion USD.
- By 2027, the industry reaches 48.6 billion USD.
- In 2028, the gross output is anticipated to be 49.77 billion USD.
Future trends to watch for include innovations in biotechnology and pharmaceuticals, regulatory changes, and the impact of global health initiatives, which could further influence growth dynamics and foster potential shifts in output levels.
